Can ChatGPT Diagnose Alzheimer's Disease?

Can ChatGPT diagnose Alzheimer's Disease (AD)? AD is a devastating neurodegenerative condition that affects approximately 1 in 9 individuals aged 65 and older, profoundly impairing memory and cognitive function. This paper utilises 9300 electronic health records (EHRs) with data from Magnetic Resonance Imaging (MRI) and cognitive tests to address an intriguing question: As a general-purpose task solver, can ChatGPT accurately detect AD using EHRs? We present an in-depth evaluation of ChatGPT using a black-box approach with zero-shot and multi-shot methods. This study unlocks ChatGPT's capability to analyse MRI and cognitive test results, as well as its potential as a diagnostic tool for AD. By automating aspects of the diagnostic process, this research opens a transformative approach for the healthcare system, particularly in addressing disparities in resource-limited regions where AD specialists are scarce. Hence, it offers a foundation for a promising method for early detection, supporting individuals with timely interventions, which is paramount for Quality of Life (QoL).

EEG-SSM: Leveraging State-Space Model for Dementia Detection

State-space models (SSMs) have garnered attention for effectively processing long data sequences, reducing the need to segment time series into shorter intervals for model training and inference. Traditionally, SSMs capture only the temporal dynamics of time series data, omitting the equally critical spectral features. This study introduces EEG-SSM, a novel state-space model-based approach for dementia classification using EEG data. Our model features two primary innovations: EEG-SSM temporal and EEG-SSM spectral components. The temporal component is designed to efficiently process EEG sequences of varying lengths, while the spectral component enhances the model by integrating frequency-domain information from EEG signals. The synergy of these components allows EEG-SSM to adeptly manage the complexities of multivariate EEG data, significantly improving accuracy and stability across different temporal resolutions. Demonstrating a remarkable 91.0 percent accuracy in classifying Healthy Control (HC), Frontotemporal Dementia (FTD), and Alzheimer's Disease (AD) groups, EEG-SSM outperforms existing models on the same dataset. The development of EEG-SSM represents an improvement in the use of state-space models for screening dementia, offering more precise and cost-effective tools for clinical neuroscience.